Regeneron Pharmaceuticals Inc (REGN)

513.69 -2.34  -0.45% NASDAQ Dec 1, 16:20 USD

Regeneron Pharmaceuticals PE Ratio:

18.78 for Dec. 1, 2020
View 4,000+ financial data types
Browse...
View Full Chart

PE Ratio Chart

Export Data
Save Image
Print Image

Historical PE Ratio Data

View and export this data going back to 2004. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Dec. 1, 2020 18.78
Nov. 30, 2020 18.86
Nov. 27, 2020 18.79
Nov. 25, 2020 18.58
Nov. 24, 2020 18.50
Nov. 23, 2020 19.14
Nov. 20, 2020 18.96
Nov. 19, 2020 18.81
Nov. 18, 2020 18.97
Nov. 17, 2020 19.67
Nov. 16, 2020 20.44
Nov. 13, 2020 20.70
Nov. 12, 2020 20.35
Nov. 11, 2020 20.75
Nov. 10, 2020 20.44
Nov. 9, 2020 20.74
Nov. 6, 2020 21.13
Nov. 5, 2020 21.52
Nov. 4, 2020 21.46
Nov. 3, 2020 20.37
Nov. 2, 2020 20.05
Oct. 30, 2020 19.87
Oct. 29, 2020 20.31
Oct. 28, 2020 20.73
Oct. 27, 2020 21.29
Oct. 26, 2020 21.41
   
Oct. 23, 2020 21.19
Oct. 22, 2020 21.04
Oct. 21, 2020 20.92
Oct. 20, 2020 21.08
Oct. 19, 2020 21.31
Oct. 16, 2020 21.92
Oct. 15, 2020 21.39
Oct. 14, 2020 21.96
Oct. 13, 2020 22.22
Oct. 12, 2020 21.99
Oct. 9, 2020 22.01
Oct. 8, 2020 21.93
Oct. 7, 2020 21.63
Oct. 6, 2020 21.26
Oct. 5, 2020 22.12
Oct. 2, 2020 20.64
Oct. 1, 2020 20.77
Sept. 30, 2020 20.46
Sept. 29, 2020 22.21
Sept. 28, 2020 22.14
Sept. 25, 2020 22.22
Sept. 24, 2020 21.58
Sept. 23, 2020 21.88
Sept. 22, 2020 22.13
Sept. 21, 2020 21.51

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

Advertisement

Price to Earnings Ratio (PE Ratio) Definition

The Price to Earnings Ratio (PE Ratio) is calculated by taking the stock price / EPS (ttm). This metric is considered a valuation metric that confirms whether the earnings of a company justifies the stock price. There isn't necesarily an optimum PE ratio, since different industries will have different ranges of PE Ratios. Because of this, PE Ratio is great to evaluate from a relative standpoint with other similar companies.

Read full definition.

PE Ratio Benchmarks

Moderna Inc --
Amgen Inc 18.15
Gilead Sciences Inc 63.02

PE Ratio Range, Past 5 Years

Minimum 14.18 Jun 06 2019
Maximum 109.10 Dec 16 2015
Average 36.93
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.